Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis | Cardiovascular Diabetology
Study selection process A total of 3161 studies were retrieved from MEDLINE and EMBASE, with an additional one…
